The Claim
Targeted knockdown of PEPCK1, but not PEPCK2, in Ras/Src tumor-bearing Drosophila fed a high-sugar diet reduces tumor growth and improves survival, demonstrating that PEPCK1 is a specific and necessary mediator of high-sugar-induced tumor progression in this model.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In fruit flies with cancer and a high-sugar diet, reducing PEPCK1 protein levels stops tumors from growing and extends lifespan, but reducing PEPCK2 has no effect.
See the scientific wording
Targeted knockdown of PEPCK1, but not PEPCK2, in Ras/Src tumor-bearing Drosophila fed a high-sugar diet significantly reduces tumor growth and improves survival, indicating that PEPCK1 is a specific and necessary mediator of high-sugar-induced tumor progression in this model.
When sugar intake is high, a gene called PEPCK1 becomes overactive in tumor cells, which triggers a chain of metabolic changes that fuel tumor growth. This enzyme boosts the production of key sugar-based molecules that turn on growth signals, block cell death, and increase sugar uptake into tumor cells. Without PEPCK1, these signals shut down, tumors stop growing, and cells die normally.
What the research says
1 studyStudy: High sugar diet promotes tumor progression paradoxically through aberrant upregulation of pepck1
When scientists turned off the PEPCK1 enzyme in cancerous fruit flies eating lots of sugar, the tumors got smaller and the flies lived longer — but turning off the similar PEPCK2 enzyme did nothing. This shows PEPCK1 is the key enzyme making sugar harmful to these tumors.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.